Desai V G, Feuers R J, Hart R W, Ali S F
Division of Genetic Toxicology, National Center for Toxicological Research/FDA, Jefferson, AR 72079-9502, USA.
Brain Res. 1996 Apr 9;715(1-2):1-8. doi: 10.1016/0006-8993(95)01255-9.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), has been demonstrated to cause selective neurotoxicity by inhibiting complex I in mitochondria, through its toxic metabolite 1-methyl-4-phenylpyridine (MPP+) which is formed during the bioactivation of MPTP by monoamine oxidase B. In this report, we have evaluated the effect of MPP+ on the 4 mitochondrial respiratory chain complexes by incubating brain mitochondria of mice at 3 different age groups with MPP+ (200 microM) and monitoring enzyme activities of complexes I, II, III, and IV at 5, 10, 15, 30, 60, and 120 min. Complexes I, III, and IV showed significant inhibition within 15 min in all the age groups studied, followed by some recovery in enzyme activities upon further incubation for complexes I and IV. However, complex II was not affected by MPP+ at any age. Our data suggest that inhibition of complexes I, III, and IV by MPP+ efficiently restrict the transport of electrons down the respiratory chain which ultimately leads to decreased ATP production. This could further aggravate oxidative stress as ATP is required for the synthesis of glutathione (GSH), one of the important scavengers of free radicals. In this study, inhibition was more severe in mitochondrial preparations from older rather than younger mice. Additionally, young animals showed faster recovery following inhibition than old animals for complex I. Impaired respiratory chain function in older animals compared to younger ones supports the hypothesis of accumulation of age-related mitochondrial DNA mutations which partly encode for subunits of complexes I, III, and IV. From this study, it seems that inhibition of complexes I, III, and IV may be the underlying cause of neurotoxicity due to MPP+ which could be intensified by age-associated dysfunction of electron transport.
1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)已被证明可通过其有毒代谢产物1-甲基-4-苯基吡啶(MPP+)抑制线粒体中的复合物I,从而导致选择性神经毒性。MPP+是在单胺氧化酶B对MPTP进行生物活化过程中形成的。在本报告中,我们通过用MPP+(200微摩尔)孵育3个不同年龄组小鼠的脑线粒体,并在5、10、15、30、60和120分钟时监测复合物I、II、III和IV的酶活性,评估了MPP+对4种线粒体呼吸链复合物的影响。在所有研究的年龄组中,复合物I、III和IV在15分钟内显示出显著抑制,随后复合物I和IV在进一步孵育后酶活性有所恢复。然而,复合物II在任何年龄都不受MPP+影响。我们的数据表明,MPP+对复合物I、III和IV的抑制有效地限制了电子沿呼吸链的传递,最终导致ATP生成减少。这可能会进一步加剧氧化应激,因为合成谷胱甘肽(GSH,一种重要的自由基清除剂)需要ATP。在本研究中,老年小鼠线粒体制剂中的抑制比幼年小鼠更严重。此外,对于复合物I,幼年动物在抑制后比老年动物恢复得更快。与幼年动物相比,老年动物呼吸链功能受损支持了与年龄相关的线粒体DNA突变积累的假说,这些突变部分编码复合物I、III和IV的亚基。从这项研究来看,复合物I、III和IV的抑制可能是MPP+导致神经毒性的根本原因,而与年龄相关的电子传递功能障碍可能会加剧这种毒性。